4/A//SEC Filing
Rosol Michael Stanley 4/A
Accession 0001437749-22-005531
CIK 0000810509other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:01 PM ET
Size
5.2 KB
Accession
0001437749-22-005531
Insider Transaction Report
Form 4/AAmended
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2021-12-27$0.00/sh+100,000$100→ 100,000 totalExercise: $1.08Exp: 2031-12-27→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest quarterly over a four-year period beginning on April 1, 2022.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:01 PM ET
- Size
- 5.2 KB